CRYSTALLINE CLOPIDOGREL NAPHTHALENESULFONATE OR HYDRATE THEREOF, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

CRYSTALLINE CLOPIDOGREL NAPHTHALENESULFONATE OR HYDRATE THEREOF, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

A monohydrate of a crystalline clopidogrel naphthalenesulfonate of formula (Ib) whose powder X-ray diffraction scan shows major peaks having I/I 0 values greater than 10% at 2¸ = 7.6, 9.7, 10.7, 11.0, 12.1, 13.6, 14.2, 15.3, 16.6, 17.0, 18.1, 18.5, 19.8, 21.5, 22.2, 23.0, 23.5, 24.3, 24.8, 25.7, 26....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KIM, CHEOL KYUNG, KIM, HAN KYONG, YUN, SANGMIN, KIM, HEE SEOCK, LEE, GWAN SUN, SUH, KWEE-HYUN, KIM, EUN SOOK, KWON, BO SUNG
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KIM, CHEOL KYUNG
KIM, HAN KYONG
YUN, SANGMIN
KIM, HEE SEOCK
LEE, GWAN SUN
SUH, KWEE-HYUN
KIM, EUN SOOK
KWON, BO SUNG
description A monohydrate of a crystalline clopidogrel naphthalenesulfonate of formula (Ib) whose powder X-ray diffraction scan shows major peaks having I/I 0 values greater than 10% at 2¸ = 7.6, 9.7, 10.7, 11.0, 12.1, 13.6, 14.2, 15.3, 16.6, 17.0, 18.1, 18.5, 19.8, 21.5, 22.2, 23.0, 23.5, 24.3, 24.8, 25.7, 26.4, 26.9, 27.3, 28.4, 29.0:
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1732932B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1732932B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1732932B13</originalsourceid><addsrcrecordid>eNqNijEKwkAQANNYiPqHfYAWJoVYrpc97-Cye1w2RaoQ5KxEBf2EvzaC9lYzMDMvXib1rWIInglMkOhrOSYKwBidOgzE1HbBCqMSSALX1-mj6iiR2DU0pE5qsFOLiSImz0dosSFAriE6TA0a6tQbDGCkidJ69cKTs6Ln374sZufx8sirLxcFWFLjNvl-G_LjPp7yNT8HittdVe6r8rCt_ljee-Y-wg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CRYSTALLINE CLOPIDOGREL NAPHTHALENESULFONATE OR HYDRATE THEREOF, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITION CONTAINING SAME</title><source>esp@cenet</source><creator>KIM, CHEOL KYUNG ; KIM, HAN KYONG ; YUN, SANGMIN ; KIM, HEE SEOCK ; LEE, GWAN SUN ; SUH, KWEE-HYUN ; KIM, EUN SOOK ; KWON, BO SUNG</creator><creatorcontrib>KIM, CHEOL KYUNG ; KIM, HAN KYONG ; YUN, SANGMIN ; KIM, HEE SEOCK ; LEE, GWAN SUN ; SUH, KWEE-HYUN ; KIM, EUN SOOK ; KWON, BO SUNG</creatorcontrib><description>A monohydrate of a crystalline clopidogrel naphthalenesulfonate of formula (Ib) whose powder X-ray diffraction scan shows major peaks having I/I 0 values greater than 10% at 2¸ = 7.6, 9.7, 10.7, 11.0, 12.1, 13.6, 14.2, 15.3, 16.6, 17.0, 18.1, 18.5, 19.8, 21.5, 22.2, 23.0, 23.5, 24.3, 24.8, 25.7, 26.4, 26.9, 27.3, 28.4, 29.0:</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120321&amp;DB=EPODOC&amp;CC=EP&amp;NR=1732932B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120321&amp;DB=EPODOC&amp;CC=EP&amp;NR=1732932B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KIM, CHEOL KYUNG</creatorcontrib><creatorcontrib>KIM, HAN KYONG</creatorcontrib><creatorcontrib>YUN, SANGMIN</creatorcontrib><creatorcontrib>KIM, HEE SEOCK</creatorcontrib><creatorcontrib>LEE, GWAN SUN</creatorcontrib><creatorcontrib>SUH, KWEE-HYUN</creatorcontrib><creatorcontrib>KIM, EUN SOOK</creatorcontrib><creatorcontrib>KWON, BO SUNG</creatorcontrib><title>CRYSTALLINE CLOPIDOGREL NAPHTHALENESULFONATE OR HYDRATE THEREOF, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITION CONTAINING SAME</title><description>A monohydrate of a crystalline clopidogrel naphthalenesulfonate of formula (Ib) whose powder X-ray diffraction scan shows major peaks having I/I 0 values greater than 10% at 2¸ = 7.6, 9.7, 10.7, 11.0, 12.1, 13.6, 14.2, 15.3, 16.6, 17.0, 18.1, 18.5, 19.8, 21.5, 22.2, 23.0, 23.5, 24.3, 24.8, 25.7, 26.4, 26.9, 27.3, 28.4, 29.0:</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNijEKwkAQANNYiPqHfYAWJoVYrpc97-Cye1w2RaoQ5KxEBf2EvzaC9lYzMDMvXib1rWIInglMkOhrOSYKwBidOgzE1HbBCqMSSALX1-mj6iiR2DU0pE5qsFOLiSImz0dosSFAriE6TA0a6tQbDGCkidJ69cKTs6Ln374sZufx8sirLxcFWFLjNvl-G_LjPp7yNT8HittdVe6r8rCt_ljee-Y-wg</recordid><startdate>20120321</startdate><enddate>20120321</enddate><creator>KIM, CHEOL KYUNG</creator><creator>KIM, HAN KYONG</creator><creator>YUN, SANGMIN</creator><creator>KIM, HEE SEOCK</creator><creator>LEE, GWAN SUN</creator><creator>SUH, KWEE-HYUN</creator><creator>KIM, EUN SOOK</creator><creator>KWON, BO SUNG</creator><scope>EVB</scope></search><sort><creationdate>20120321</creationdate><title>CRYSTALLINE CLOPIDOGREL NAPHTHALENESULFONATE OR HYDRATE THEREOF, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITION CONTAINING SAME</title><author>KIM, CHEOL KYUNG ; KIM, HAN KYONG ; YUN, SANGMIN ; KIM, HEE SEOCK ; LEE, GWAN SUN ; SUH, KWEE-HYUN ; KIM, EUN SOOK ; KWON, BO SUNG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1732932B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KIM, CHEOL KYUNG</creatorcontrib><creatorcontrib>KIM, HAN KYONG</creatorcontrib><creatorcontrib>YUN, SANGMIN</creatorcontrib><creatorcontrib>KIM, HEE SEOCK</creatorcontrib><creatorcontrib>LEE, GWAN SUN</creatorcontrib><creatorcontrib>SUH, KWEE-HYUN</creatorcontrib><creatorcontrib>KIM, EUN SOOK</creatorcontrib><creatorcontrib>KWON, BO SUNG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KIM, CHEOL KYUNG</au><au>KIM, HAN KYONG</au><au>YUN, SANGMIN</au><au>KIM, HEE SEOCK</au><au>LEE, GWAN SUN</au><au>SUH, KWEE-HYUN</au><au>KIM, EUN SOOK</au><au>KWON, BO SUNG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CRYSTALLINE CLOPIDOGREL NAPHTHALENESULFONATE OR HYDRATE THEREOF, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITION CONTAINING SAME</title><date>2012-03-21</date><risdate>2012</risdate><abstract>A monohydrate of a crystalline clopidogrel naphthalenesulfonate of formula (Ib) whose powder X-ray diffraction scan shows major peaks having I/I 0 values greater than 10% at 2¸ = 7.6, 9.7, 10.7, 11.0, 12.1, 13.6, 14.2, 15.3, 16.6, 17.0, 18.1, 18.5, 19.8, 21.5, 22.2, 23.0, 23.5, 24.3, 24.8, 25.7, 26.4, 26.9, 27.3, 28.4, 29.0:</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP1732932B1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title CRYSTALLINE CLOPIDOGREL NAPHTHALENESULFONATE OR HYDRATE THEREOF, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T03%3A02%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KIM,%20CHEOL%20KYUNG&rft.date=2012-03-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1732932B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true